Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Niraxostat

Product Specifications

UNSPSC Description

Niraxostat (Y-700; Piraxostat) is an orally active xanthine oxidoreductase (XOR) inhibitor used in the study of hyperuricemia and other diseases in which XOR may be involved[1].

Target Antigen

Xanthine Oxidase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/niraxostat.html

Solubility

DMSO : 83.33 mg/mL (ultrasonic)

Smiles

O=C(C1=CN(C2=CC=C(OCC(C)(C)C)C(C#N)=C2)N=C1)O

Molecular Weight

299.32

References & Citations

[1]Fukunari A, et al. Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J Pharmacol Exp Ther. 2004 Nov;311(2):519-28.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-14669/Niraxostat-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-14669/Niraxostat-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

206884-98-2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Kdr Mouse shRNA Plasmid (Locus ID 16542)
TL501171 1 Kit

Kdr Mouse shRNA Plasmid (Locus ID 16542)

Ask
View Details
(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
PC111478-01 50 mg

(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

Ask
View Details
(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
PC111478-02 100 mg

(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

Ask
View Details
(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
PC111478-03 250 mg

(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

Ask
View Details
(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
PC111478-04 1 g

(3S,8R,9S,10R,13S,14S) -10,13-dimethyl-17- (trifluoromethylsulfonyloxy) -2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

Ask
View Details
E cadherin Polyclonal Antibody FITC Conjugated
C91104FITC 100 µL

E cadherin Polyclonal Antibody FITC Conjugated

Ask
View Details